These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 33219822)

  • 1. Bone Fragility Fractures in CKD Patients.
    Pimentel A; Ureña-Torres P; Bover J; Luis Fernandez-Martín J; Cohen-Solal M
    Calcif Tissue Int; 2021 Apr; 108(4):539-550. PubMed ID: 33219822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease.
    Hampson G; Elder GJ; Cohen-Solal M; Abrahamsen B
    Endocrine; 2021 Sep; 73(3):509-529. PubMed ID: 33974225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fragility fracture in the Chronic Kidney Disease (CKD)].
    Fusaro M; Aghi A; Mereu MC; Giusti A
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of osteoporosis in patients with chronic kidney disease.
    Abdalbary M; Sobh M; Elnagar S; Elhadedy MA; Elshabrawy N; Abdelsalam M; Asadipooya K; Sabry A; Halawa A; El-Husseini A
    Osteoporos Int; 2022 Nov; 33(11):2259-2274. PubMed ID: 35748896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and fragility fracture.
    Kazama JJ
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):46-52. PubMed ID: 28012057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations.
    Bover J; Ureña-Torres P; Torregrosa JV; Rodríguez-García M; Castro-Alonso C; Górriz JL; Laiz Alonso AM; Cigarrán S; Benito S; López-Báez V; Lloret Cora MJ; daSilva I; Cannata-Andía J
    Nefrologia (Engl Ed); 2018; 38(5):476-490. PubMed ID: 29703451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.
    Jørgensen HS; David K; Salam S; Evenepoel P;
    Calcif Tissue Int; 2021 Apr; 108(4):496-511. PubMed ID: 33586002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of fracture risk in chronic kidney disease.
    Torres PAU; Cohen-Solal M
    J Nephrol; 2017 Oct; 30(5):653-661. PubMed ID: 28386879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.
    Iwasaki Y; Kazama JJ; Fukagawa M
    Biomed Res Int; 2017; 2017():3485785. PubMed ID: 28421193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures].
    Giusti A; Fusaro M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone biopsy: an ally in the management of fragility fractures in chronic kidney disease.
    Aguiar F; Meng C; Pereira L; Brito I; Frazão JM
    Acta Reumatol Port; 2018; 43(3):201-209. PubMed ID: 30414368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current therapeutic approach of chronic kidney disease-mineral and bone disorder.
    Zaimi M; Grapsa E
    Ther Apher Dial; 2024 Oct; 28(5):671-689. PubMed ID: 38898685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in CKD-Associated Osteoporosis.
    Khairallah P; Nickolas TL
    Curr Osteoporos Rep; 2018 Dec; 16(6):712-723. PubMed ID: 30353319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.
    Cannata-Andía JB; Martín-Carro B; Martín-Vírgala J; Rodríguez-Carrio J; Bande-Fernández JJ; Alonso-Montes C; Carrillo-López N
    Calcif Tissue Int; 2021 Apr; 108(4):410-422. PubMed ID: 33190187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate and bone fracture risk in chronic kidney disease patients.
    Fusaro M; Holden R; Lok C; Iervasi G; Plebani M; Aghi A; Gallieni M; Cozzolino M
    Nephrol Dial Transplant; 2021 Feb; 36(3):405-412. PubMed ID: 31620773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.